Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Re-Education of Arm and Hand function following stroke
ISRCTN ISRCTN12548377
ClinicalTrials.gov identifier
Public title Re-Education of Arm and Hand function following stroke
Scientific title A randomised controlled trial of an accelerometer triggered functional electrical stimulation (FES) device for recovery of upper limb function in chronic stroke patients
Acronym REAcH
Serial number at source TSA 2008/2
Study hypothesis That accelerometer triggered functional electrical stimulation (FES) to the finger, thumb, wrist and elbow extensors may be a useful treatment to assist upper limb recovery of function following stroke and is more effective than conventional physiotherapy methods.
Lay summary
Ethics approval Wiltshire Research Ethics Committee approved on the 16th March 2009 (ref: 09/H0104/9)
Study design Interventional randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke more than 6 months post-cerebrovascular accident (CVA)
Participants - inclusion criteria 1. First stroke leading to hemiplegia
2. Aged 18 years and above (no upper age limit), either sex
3. Reduced hand and arm function, limiting voluntary elbow extension and hand opening
4. Medically stable
5. Able to understand and comply with assessment procedures
6. Able to give informed consent
7. Minimum 45 degrees active shoulder flexion
8. Able to initiate elbow extension
9. Enough active wrist and finger extension to pick up and release a 2.5 cm cube (easiest task in grasp section of Action Research Arm Test [ARAT])
10. Responds to stimulation to open the hand
Participants - exclusion criteria 1. An ARAT score of greater than 40 (out of 57) at initial assessment
2. Any existing orthopaedic condition affecting the upper limb
3. Cardiac pacemaker
4. Painful shoulder
5. Fixed contractures at elbow, wrist or fingers
6. Pregnancy
7. Malignancy in the area of the electrodes
8. A history of poorly controlled epilepsy
Anticipated start date 01/04/2009
Anticipated end date 31/03/2012
Status of trial Completed
Patient information material Can be found at http://www.salisburyfes.com/pdfs/pat%20info%20SA%20ReACH%20salisbury%20v1.pdf
Target number of participants 60
Interventions Intervention group:
Functional electrical stimulation of the wrist, finger, thumb and elbow extensors, triggered using a movement sensor (an accelerometer) detecting an attempt to reach forward to grasp an object. Stimulation is delivered through self adhesive skin electrodes placed over the extensor muscles. A stimulator/controller is carried on the arm. The stimulation helps complete the reaching function by extending the elbow and wrist and opening the hand.

Comparator group:
Conventional physiotherapy exercises mimicking the action of the device but without the assistance of FES.

Both groups use the treatment for 12 weeks. Outcomes are assessed then and 12 weeks later.
Primary outcome measure(s) Action Research Arm Test (ARAT). The ARAT was chosen as it includes elements of both shoulder, arm and hand function.

Assessments are made at the beginning of the baseline period (-6 weeks) at the end of the baseline (week 0), at the end of the treatment period (week 12) and 12 weeks after the intervention is removed (week 24).
Secondary outcome measure(s) Impairment:
1. Fugl-Meyer Test (FM): a measure of impairment commonly reported in similar studies in the literature, so enabling comparison with other trials
2. Modified Ashworth Scale (MAS): to measure elbow, wrist and finger spasticity. Spasticity is a major inhibition to the use of the hand and high tone levels can be distressing. Increased tone would be an indication of an adverse response to treatment.

Function:
3. Box and Block Test (B&B): a measure of dexterity. This functional test has been added as it has fewer elements of subjectivity than the ARAT.

Activities of daily living:
4. Canadian Occupational Performance Measure (COPM): to assess patient perception of their performance and their satisfaction with activities of daily living

Quality of life:
5. Stroke Impact Scale (SIS): a measure of the impact of stroke on quality of life

Cost analysis:
6. Cost effectiveness and cost utility: for the cost-effectiveness analyses an appropriate clinical measure will be chosen from the above outcome measures. For the cost-utility study health outcomes will be measured by the health states reported by patients using the EQ-5D questionnaire. These health profiles will be converted to utility values using the published population utility tariffs for the EQ-5D. Costs related to service use incurred by the research volunteers will be recorded using a purpose designed Client Service Receipt Inventory (CSRI) form. Treatment cost will be recorded using case report forms (TCRF) to be completed by the clinical staff throughout the project.

Research Volunteer perspective of treatment:
7. Use of Device Questionnaire (UDQ): this custom questionnaire will be used to systematically record the research volunteers experiences and opinions about their treatment

Compliance:
8. Each subject will be asked to complete a compliance diary

Safety:
9. Safety will be assessed by recording adverse incidents

Assessments are made at the beginning of the baseline period (-6 weeks) at the end of the baseline (week 0), at the end of the treatment period (week 12) and 12 weeks after the intervention is removed (week 24).
Sources of funding The Stroke Association (UK) (ref: TSA 2008/2)
Trial website
Publications
Contact name Dr  Paul  Taylor
  Address The National Clinical FES Centre
Salisbury District Hospital
  City/town Salisbury
  Zip/Postcode SP2 8BJ
  Country United Kingdom
  Tel +44 (0)1722 429119
  Fax +44 (0)1722 425263
  Email p.taylor@salisburyfes.com
Sponsor Salisbury NHS Foundation Trust (UK)
  Address Salisbury District Hospital
Odstock Road
  City/town Salisbury
  Zip/Postcode SP2 8BJ
  Country United Kingdom
  Tel +44 (0)1722 336262
  Email Stef.Scott@salisbury.nhs.uk
  Sponsor website: http://www.salisbury.nhs.uk/
Date applied 14/04/2009
Last edited 05/05/2009
Date ISRCTN assigned 05/05/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central